U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07506876) titled 'Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer' on March 26.
Brief Summary: The usual approach to care for hormone receptor positive, HER2 positive breast cancer is chemotherapy and HER2 targeted therapy followed by endocrine therapy and surgery.
The purpose of this Research Study is to see if taking endocrine therapy with the chemotherapy and HER2 directed therapy increases patients response to therapy at the time of surgery
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Breast Cancer - Infiltrating Ductal Carcinoma
HER-2 Positive Breast Cancer
Intervention:
DRUG: Concurrent endocr...